We’re thrilled to share the exciting news of a powerful new alliance aimed at strengthening global patient care for people living with chronic respiratory diseases. In the Advocacy Beyond Borders video, GAAPP teams up with EUFOREA, a leader in medical innovation and science, to expand upon our shared missions of bridging gaps in information, improving care exponentially, and supporting people with chronic respiratory diseases around the world. This collaboration will leverage EUFOREA’s clinical and scientific expertise and GAAPP’s extensive global patient advocacy network. The partnership builds on our commitment to empower patients through awareness, education, advocacy, and research, our four key pillars that drive meaningful change. In this video, you will hear about the:

  1. Importance of increasing access to accurate information for all with chronic
    respiratory disease
  2. Most pressing needs of people with chronic respiratory conditions and how those
    can be addressed
  3. Importance of collective global advocacy efforts in effecting change, and what
    topics are being championed by GAAPP and EUFOREA
  4. Details of the ADAP3T Project: Airways Disease Action Plan for Predicted and
    Personalized Treatment
  5. Most critical issues GAAPP and EUFOREA will address, including access to
    patient-centered care
  6. Steps to measure the success of these initiatives

Watch the full announcement here to hear from GAAPP’s President and CEO Tonya Winders and Dr. Xander Bertels, EUFOREA Head of Advocacy and ADAP3T Medical Liaison at EUFOREA about how this collaboration will work to elevate patient care on a global scale.